Drug Prescription and Administration Record
|
|
|
- Gwen Mosley
- 5 years ago
- Views:
Transcription
1 Chart No. this admission Drug Prescription and Administration Record Patient s Name: of Admission: Chart Start : Chart Finish : NHS No: Consultant Code: Ward: ALERT: of Birth: ADDITIONAL CAUTIONS FOR PRESCRIBING (e.g. renal failure, gastric ulceration etc) Tick if on CHEMOTHERAPY OTHER CHARTS in use Tick Box: Syringe driver Opioid patch Other Other DRUG SENSITIVITIES & REACTIONS ature: : ONCE ONLY / NURSE LED PRESCRIPTIONS See Approved Homely Remedies list Medicine Dose Route Instructions Start time Doctor s signature Time given Nurse s signature REMOTE PRESCRIPTIONS File Emergency Telephone Prescription of Drugs form in notes and document any doses given here Medicine Dose Route Instructions Time given Specify text/ etc Nurse s signature Dr. signature (next working day) CODE FOR USE ON REGULAR AND PRN CHART R = drug refused by patient N = drug not in stock U = patient too unwell W = drug withheld O = patient out P = patient self-administration
2 INTRAVENOUS THERAPY AND SUBCUTANEOUS INFUSION FOR INFUSION FLUIDS, BLOOD, PLASMA AND DRUGS BY ONE CONTINUOUS INFUSION No additions to be made to blood products or sodium bicarbonate. For information on additive compatibilities contact acy Medicines Information. Infusion Fluid Additions to Infusion Time to Run or ml/hr Prescriber s signature Batch No. Pump Asset No. Time start Nurses signiture x2 Time end Amount infused Type/Strength Volume Route / Site Drug Dose Print name
3 DRUG SENSITIVITIES: DIAGNOSIS: Route Key IM = Intramuscular SC = Subcutaneous TOP = Topical NEB = Nebulised INH = Inhalation IV = Intravenous PR = Per Rectum PO = Oral / Enteral SL = Sublingual PV = Per Vaginam PEG = Percutaneous endoscopic gastrostomy BUC = Buccal TD = Transdermal NAS = Nasal REGULAR PRESCRIPTIONS MONTH DATE Drug Dose Route Frequency Start Special Instruction / Indication Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800 Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800 Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800 Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800 Drug 0800 Dose Route Frequency Start Special Instruction / Indication 1800
4 REGULAR PRESCRIPTIONS Continued... MONTH DATE Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start
5 REGULAR PRESCRIPTIONS Continued... MONTH DATE Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start
6 REGULAR PRESCRIPTIONS Continued... MONTH DATE Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start
7 REGULAR PRESCRIPTIONS Continued... MONTH DATE Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start Dose Route Frequency Start
8 PRN PRESCRIPTIONS Drug Time Dose Route Sig Time Dose Route Sig MIDAZOLAM Dose / Range Route Max Freq Start IM only to be used in the event of a CRISIS (e.g. massive haemorrhage, airway obstruction) Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start
9 PRN PRESCRIPTIONS Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start
10 PRN PRESCRIPTIONS Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start
11 PRN PRESCRIPTIONS Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start Drug Time Dose Route Sig Time Dose Route Sig Dose / Range Route Max Freq Start
12 SUBCUTANEOUS SYRINGE DRIVER PRESCRIPTION CHART Prescription to be monitored using Checks In Use form 1 Dose 2 Dose (Dr) Started (Dr) Started Stopped Stopped 3 Dose 4 Dose (Dr) Started (Dr) Started Stopped Stopped 5 Dose 6 Dose (Dr) Started (Dr) Started Stopped Stopped 7 Dose 8 Dose (Dr) Started (Dr) Started Stopped Stopped
[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]
![[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]](/thumbs/92/110296570.jpg "[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]")
[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose
Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016
Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply
For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.
Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative
MORPHINE ADMINISTRATION
Introduction Individualised Administration Drug of Choice Route of Administration & Doses Monitoring of Neonates & high risk patients Team Management Responsibility Morphine Protocol Flow Chart Introduction
Diamorphine 4 hour. alfentanil (500microgram/mL) Calculated by dividing 24 hour oral morphine dose by 30
If more information is required please seek help from specialist palliative care pioid dose conversion chart, syringe driver doses, rescue/prn doses and opioid patches Use the conversion chart to work
Palliative Care Impact Survey
September 2018 Contents Introduction...3 Headlines...3 Approach...4 Findings...4 Which guideline are used...4 How and where the guidelines are used...6 Alternative sources of information...7 Use of the
ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug
COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER
Appendix: Sample prescription form. The following sample prescription form gives examples of sections found in most hospital prescription forms.
The hands-on guide to practical prescribing Oliver Jones, Nandan Gautam Copyright 2004 by Blackwell Publishing Appendix: Sample prescription form The following sample prescription form gives examples of
Care in the Last Days of Life
Care in the Last Days of Life Introduction This guideline is an aid to clinical decision making and good practice in person-centred care for patients who are deteriorating and at risk of dying. The patient
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
Pharmaceutics I صيدالنيات 1. Unit 2 Route of Drug Administration
Pharmaceutics I صيدالنيات 1 Unit 2 Route of Drug Administration 1 Routs of Drug administration The possible routes of drug entry into the body may be divided into two classes: Parenteral Rout Enteral Rout
Algorithms for Symptom Management. In End of Life Care
Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the
PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE
PAIN AND SYMPTOM MANAGEMENT GUIDANCE IN THE LAST DAYS OF LIFE Reference: DCM029 Version: 1.1 This version issued: 07/06/18 Result of last review: Minor changes Date approved by owner (if applicable): N/A
UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17
LJW3 UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2016/17 FOUNDATIONS OF MEDICINES MANAGEMENT MODULE CODE: HLT4085
PCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING
Attach ADR Sticker THESE INSTRUCTIONS EXPLAIN WHEN TO MAKE A CLINICAL REVIEW OR RAPID RESPONSE CALL, YOUR LOCAL ESCALATION PROTOCOL WILL EXPLAIN HOW TO MAKE A CALL PCA ALLERGIES & ADVERSE DRUG REACTIONS
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,
Platelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction.
s Aspirin Platelet aggregation inhibitor. Anti-inflammatory agent and an inhibitor of platelet function. Useful agent in the treatment of various thromboembolic diseases such as acute myocardial infarction.
REGISTRATION ASSESSMENT SITTINGS Part 1 example questions. 1. Questions 1 to 12 are examples from part 1 of the registration assessment.
Notes REGISTRATION ASSESSMENT SITTINGS 2018 Part 1 example questions 1. Questions 1 to 12 are examples from part 1 of the registration assessment. 2. The answers are on page 14. 3. Unless specified, give
Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth)
Guidelines: EOLC Symptom Control for Patients with Normal Renal Function (in Wandsworth) Policy Number : DC020 Issue Date: October 2014 Review date: October 2016 Policy Owner: Head Community Services Monitor:
Palliative care for heart failure patients. Susan Addie
Palliative care for heart failure patients Susan Addie Treatments The most common limiting and distressing complaint is of fatigue and breathlessness. Optimal treatment strategies relieve symptoms, improves
PAIN MANAGEMENT Patient established on oral morphine or opioid naive.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
Please inform the Diabetes Nurse Specialist that this patient has been admitted within 24hrs of admission.
Adult Diabetic Ketoacidosis Care Bundle (V1. Issued October 2014 Review October 2015) Improving patient care This pack includes: DKA Management Guideline Name: (Patient Addressograph) DOB: Hospital No:
Paediatric Prescribing Pocket Guide September 2014 (Version 1)
PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors
End of life prescribing guidance
End of life prescribing guidance Introduction This guidance has been prepared to ASSIST IN DECISION MAKING for the prescribing and monitoring of medicines useful in the management of symptoms commonly
Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July Gosport Hospital Report & RUH Assurance
Report to: Public Board of Directors Agenda item: 11 Date of Meeting: 25 July 2018 Title of Report: Status: Board Sponsor: Author: Appendices Gosport Hospital Report & RUH Assurance For Information Dr
PAIN MANAGEMENT Person established taking oral morphine or opioid naive.
PAIN MANAGEMENT Person established taking oral morphine or opioid naive. Important; it is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
Conservative Management of Uraemia
Conservative Management of Uraemia Information for Health Professionals Renal Department The York Hospital and Scarborough Hospital Tel: 01904 725370 For more information, please contact: The Renal Specialist
MOD 4: Medication Administration
NSE22 Page 1 1. MOD 4: Medication Administration October1310 8:12 PM The CNO identifies eight rights of medication administration. Identify the eight rights and the rationale for each Right Client give
survey Parenteral anti-epileptics What is your experience? May July 2015
Parenteral anti-epileptics What is your experience? May July 2015 Number of responses = 99 1a) In patients with pre-existing epilepsy controlled by PO medication that are imminently dying (prognosis
PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain
Index No: MMG43 PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Version: 3.1 (Includes anti-emetics and naloxone) Date ratified: July 2013 Ratified by: (Name of Committee) Name
SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRESCRIPTION & ADMINISTRATION RECORD (SPAR) Name: Address: Postcode: Date of Birth: NHS Number:
FILE IN PATIENT S COMMUNITY HEALTH RECORD FOLDER : SUBCUTANEOUS AS REQUIRED & SYRINGE PUMP PRERIPTION & ADMINISTRATION RECORD (SPAR) Abbreviations used in this document to be listed here with the full
PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS
PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL IMPAIRMENT
ANTICIPATORY PRESCRIBING FOR PATIENTS AT END OF LIFE WITH RENAL Doses of opiates must be proptional to current analgesic medication Please refer ALL patients on Methadone Ketamine to SPCT f advice. Patients
Renal Prescribing at End of Life Guidance for Anticipatory prescribing for patients in renal failure (egfr<30) at the end of life
Guidance for Anticipatory prescribing for patients in renal failure (egfr
Chapter 2 is a general introduction to the drug administration
Chapter 2 Safe and Accurate Drug Administration Chapter Overview Chapter 2 is a general introduction to the drug administration process. It introduces the student to the role of the person who administers
Drug CHAPTER 2. Pharmacologic Principles. NDEG 26A Eliza Rivera-Mitu, RN, MSN. Pharmacology. Drug Names. Pharmacologic Principles. Drug Names (cont'd)
CHAPTER 2 Pharmacologic Principles NDEG 26A Eliza Rivera-Mitu, RN, MSN Drug Any chemical that affects the physiologic processes of a living organism Pharmacology The study or science of drugs Drug Names
MEDICATION OR OTHER SUBSTANCE
Patient Safety Event Report Hospital MEDICATION OR OTHER SUBSTANCE Use this form to report any patient safety event or unsafe condition involving a substance such as a medications, biological products,
SYRINGE DRIVER MEDICATIONS
SYRINGE DRIVER MEDICATIONS Christine Hull & Anita Webb Staff Nurses, Hospice in the Home 2015 Analgesics:- Groups of Medication used in Syringe Drivers Morphine sulphate Diamorphine Oxycodone Alfentanil
MEDICATION OR OTHER SUBSTANCE
Patient Safety Event Report Hospital MEDICATION OR OTHER SUBSTANCE Use this form to report any patient safety event or unsafe condition involving a substance such as a medications, biological products,
Symptom Management Guidelines for End of Life Care
Symptom Management Guidelines for End of Life Care The following pages are guidelines for the management of common symptoms in the last few days of life. General principles: 1. Consider how symptoms can
CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259
Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: Controlled Document Number: Version Number: 1 Controlled Document Sponsor:
1. Intrathecal must never be abbreviated to IT on a prescription form True / False
Appendix 1: Intrathecal SACT Assessment Questions Core General Questions must be completed by all staff. 1. Intrathecal must never be abbreviated to IT on a prescription form 2. Intrathecal SACT must be
Intravenous Immunoglobulin (IVIg) prescribing guidance
Intravenous Immunoglobulin (IVIg) prescribing guidance Kejal Mehta (Specialist Pharmacist) [December 2016] Review Date: December 2017 Contents Introduction:... 2 Prior to Intravenous immunoglobulin (IVIg)
BREATHLESSNESS MANAGEMENT
Guideline Name: Breathlessness BACKGROUND Breathlessness is a common symptom in patients with cancer, end-stage heart failure and end-stage chronic obstructive pulmonary disease (COPD). There are many
UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016
ljs7 UNIVERSITY OF BOLTON SCHOOL OF HEALTH AND HUMAN SCIENCES BSC (HONS) PRE-REGISTRATION NURSING EDUCATION (ADULT) SEMESTER ONE EXAMINATION 2015/2016 FOUNDATIONS OF MEDICINES MANAGEMENT MODULE CODE: HLT4085
Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)
Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients) Introduction This guideline is designed to provide a framework for patients to administer
HOW TO MANAGE AND ADMINISTER THE TRIAL TREATMENT
HOW TO MANAGE AND ADMINISTER THE TRIAL TREATMENT Protocol Code: ISRCTN11225767 How to manage and administer the trial treatment version 2.0 date 23/07/2017 What is the trial treatment? Random allocation
Trust Guideline for the Management of Patient Controlled Analgesia (PCA) in Adults
Patient Controlled Analgesia (PCA) in Adults A clinical guideline recommended for use For Use in: In all Clinical Areas By: Anaesthetists, Ward Nurses, Recovery Staff Acute Pain Service Staff For: Adult
Ketorolac injection. Supportive care
Supportive care Ketorolac injection Supportive care: specialist medicines This leaflet provides information on a medicine called ketorolac which is used to treat pain that is difficult to control. It is
End of Life Care. Dr Anne Garry Consultant in Palliative Medicine
End of Life Care Dr Anne Garry Consultant in Palliative Medicine Concerns voiced both by public and professionals.. Implementation and on-going training highly variable across country Decisions made by
Supporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety
Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of
Acute Stroke with Alteplase Administration Order Set
Review Due Date: 2017 October PATIENT CARE DERS Weight: Adverse Reactions or Intolerances Drug No Yes (list) Food No Yes (list) _ Latex No Yes Admission Admit to Neurology service: Dr. Critical Care Diagnosis:
IV Referral Standards for OPAT Services
pecialist harmacy ervice Medicines Use and afety IV Referral tandards for OAT ervices andra Wolper Associate Director Medicines Use and afety Division pecialist harmacy ervices pecialist harmacy ervice
MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life
MMG035 Symptom Management Guidelines for a Person thought to be in the Last Few Days and Hours of Life The following pages are guidelines for the management of common symptoms for a person thought to be
IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM
BACKGROUND IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM SUMMARY OF ASSESSMENT AND ITS FINDINGS Colistimethate sodium (colistin sulfomethate sodium) is licensed in the UK to be given
GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)
GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter
Regional Breathlessness Audit - Case Note Survey. 1. Introduction. Regional Breathlessness Audit - Case Note Survey. 2.
Regional Breathlessness Audit - Case te Survey 1. Introduction Please complete this form for your case note review. Cases used may be PROSPECTIVE AND/OR RETROSPECTIVE. Please log as many cases as you can.
Chapter : Sources and Bodily Effect of Drugs
Systemic Effect- drug acts in a widespread area away from the administration site Ex: Tylenol rectal suppository- given rectally but is absorbed and distributed thru the body to cause a reduction in fever
Medication Safety Presentation
Appendix E Aid 1: Sample Event Poster Medication Safety Presentation Do YOU know your role on the healthcare team? Do YOU know the questions to ask your pharmacist? Do YOU know safe medication practices?
Introduction to Pharmacokinetics
- 1 - Introduction to Pharmacokinetics Outline accompanies required webcast for Marie Biancuzzo s Lactation Exam Review and Marie Biancuzzo s Comprehensive Lactation Course Notes We will not cover this
Medication Administration and Documentation. A NC Approved CE Class offered by
Medication Administration and Documentation A NC Approved CE Class offered by Common Medical Abbreviations - Doses gm = gram gtt = drop mg = milligram ss = 1/2 mcg = microgram oz = ounce cc = cubic centimeter
This document expires on Patient Group Direction No. VI 11
Patient Group Direction (PGD) for The Administration of Combined Inactivated Hepatitis A & Hepatitis B Vaccine (Twinrix adult, Twinrix paediatric) to Adults and Children over one year by Registered Nurses
Protocol for administration of when required Medicines in Care Homes
Protocol for administration of when required Medicines in Care Homes Rationale: MAR charts can become very confusing when completing when required (prn) medicines, particularly when the box size is small
Part 2: Pain and Symptom Management Nausea and Vomiting
Part 2: Pain and Symptom Management Nausea and Vomiting Effective Date: February 22, 2017 Key Recommendations Select anti-nausea medication based on the etiology of the nausea and vomiting. Assessment
September 2014 V0.17. Paediatric Daily Fluid Prescription & Balance Chart
September 14 V0.17 Aims and outcomes of session. Aim: To provide guidance on correctly completing the paediatric daily fluid prescription & balance chart. Outcomes: Demonstrate the ability to: calculate
Attach patient label here. Physician Orders ADULT: Palliative Care Plan
Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase T;N, Phase: Palliative Care Phase, When to Initiate: Palliative Care Phase Admission/Transfer/Discharge Patient Status Initial
EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE
EAST LANCASHIRE SPECIALIST PALLIATIVE CARE TEAM EAST LANCASHIRE GUIDELINES FOR THE MANAGEMENT OF SYMPTOMS IN THE LAST DAYS OF LIFE Reviewed and updated August 2009 Next review date August 2011 Approved
What s New 2003? What new treatments? What have you discontinued? More information please!
What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?
ADULT (>16) ACUTE SICKLE PAIN GUIDELINE
ADULT (>16) ACUTE SICKLE PAIN GUIDELINE ID 2013 065 Author s Name Dr Anna Wood Author s Job Title Consultant Haematologist Division Consultant Haematologist Department Haematology Version number 3 Ratifying
Pathology Service User Guide Haematology
Pathology Service User Guide Haematology St Richard s This section of the Pathology Service User Guide includes: Anticoagulant Therapy Information about the Anticoagulant Clinic Low Molecular Weight Heparin
Chapter 7. Principles of Pharmacology
Chapter 7 Principles of Pharmacology Introduction Administering medications is a serious business. Medications may alleviate pain and improve patient s well-being. Used inappropriately, may cause harm
NUH Medicines Policy: Code of Practice
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST NUH Medicines Policy: Code of Practice THE USE OF SYRINGES TO ADMINISTER FLUSHES, FEEDS AND MEDICATION VIA THE ORAL AND ENTERAL ROUTES POLICY Reference CL/MM/037
Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45
Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45 1. Your diabetic patient is to be started on an insulin drip at 8 units/hour. The insulin is supplied: 100 units in
Palliative care for patients with brain cancer
Palliative care for patients with brain cancer Lyn Cave Clinical Nurse Specialist Palliative Care Hospital2Home (H2H) Dr Jayne Wood Clinical Lead Palliative Care The Royal Marsden and Royal Brompton Palliative
Results of a one-year, retrospective medication use evaluation. Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital
Results of a one-year, retrospective medication use evaluation Joseph Ladd, PharmD PGY-1 Pharmacy Resident BHSF Homestead Hospital Briefly review ketamine s history, mechanism of action, and unique properties
British Columbia Medical Assistance in Dying Prescription
British Columbia Medical Assistance in Dying Prescription Date: Page 1 of 6 Upon completion of MAID: 1) to provide copy of MAR to Pharmacist for reconciling the return of unused and partially used medications
WITH APPLICATIONS TO : ; : GENERAL AND SPECIALTY AREAS
f Fourth Edition WITH APPLICATIONS TO : ; : GENERAL AND SPECIALTY AREAS Joyce LeFever Kee, RN, MS Associate Professor Emerita College of Health and Nursing Sciences University of Delaware Newark, Delaware
Pharmacology. Pharmacology. Pharmacology. Safety the ultimate goal. Patient advocate. Responsible = responsive
Safety the ultimate goal Patient advocate Responsible = responsive Correct medication history and administration Be aware of specific facility guidelines May be responsible for obtaining, maintaining,
Prescribing Examples: Basics
Prescribing Examples: Basics 7 0 Pregabolin 5 50mg 05.. 5 6 7 8 9 5 6 5 5 5 5 50 50 50 50 75 75 RF RF RF RF RF RF 5 5 5 5 50 50 50 PJ TF PJ PJ TF TF TF 50 75 75 75 75 TF A: REGULAR PRERIPTION SHEET 5 6
Part 1 Principles and Routes of Medication Administration
1 Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration 2 Caution: Administering medications is business Always take appropriate Standard measures to reduce your
Essential Shared Care Agreement (South Staffordshire): Aciclovir Administration in the Community
E088 Essential Shared Care Agreement (South Staffordshire): Aciclovir Administration in the Community Patient s name: DOB NHS Number Patient s address: Consultant Note: Shared care agreement sets out a
Physician Orders Pediatric: LEB ED Asthma Plan
LEB ED Triage Standing SOB/Wheeze Asthma Non Categorized Criteria: Patients greater than 2 years of age with a history of asthma or airway active disease or two or more previous illnesses treated with
Clinical Practice Guidelines Edition (Updated February 2018)
The Formulary is published by the Pre-Hospital Emergency Care Council (PHECC) to support Emergency First Responders to be competent in the use of medications permitted under Clinical Practice Guidelines
Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care
Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage
Unit 204 Assist with the assembly of prescribed items
Element 1 Assemble prescribed 171 172 Element 1 Assemble prescribed Background Assembling prescribed is a complex process. The two main components of this process are labelling and dispensing. It is essential
Olanzapine Long-Acting Injection (Zypadhera ) - Guidelines for Prescribing and Administration (Version 3 May 2015)
1. Key Points Olanzapine Long-Acting Injection (Zypadhera ) - Guidelines for Prescribing and Administration (Version 3 May 2015) 1.1 Olanzapine long acting injection (LAI) is indicated for the maintenance
Supportive Care. End of Life Phase
Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of
Sedation in children and young people. Appendix J. Sedation for diagnostic and therapeutic procedures in children and young people
SEDATION IN CHILDREN AND YOUNG PEOPLE 1 Sedation in children and young people Sedation for diagnostic and therapeutic procedures in children and young people Appendix J 2 SEDATION IN CHILDREN AND YOUNG
Syringe driver in Palliative Care
Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24
Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.
Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients
Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always
1 3 4 5 6 7 8 9 10 Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always take appropriate Standard measures
Chapter 7. National EMS Education Standard Competencies (1 of 5) National EMS Education Standard Competencies (2 of 5) Principles of Pharmacology
Chapter 7 Principles of Pharmacology National EMS Education Standard Competencies (1 of 5) Pharmacology Applies fundamental knowledge of the medications that the EMT may assist/administer to a patient
patient group direction
DIAZEPAM (RECTAL) v01 1/8 DIAZEPAM (RECTAL) PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care
Renal function: Known CKD AKI
Chart: 1 2 3 of 1 2 3 Site: Lister QE2 MVCC (circle) (circle) Adult Medication scription and Monitoring Record for Patients with Diabetes (Inpatient Chart) Patient Name: Address: of Admission: Weight (kg):
Renal Palliative Care Last Days of Life
Renal Palliative Care Last Days of Life Introduction This guideline is an aid to clinical decision-making and good practice for patients with stage 4-5 chronic kidney disease (egfr
Suboptimal hydration harms patients.
Suboptimal hydration harms patients. NHS Fife is committed to improving hydration management. To achieve this we need your help! In 2014 new fluid balance charts were implemented in the Victoria Hospital,
Howida Kamal, Ph.D Ass. Prof. of Pharmaceutics, Cairo University
Pharmacy Howida Kamal, Ph.D Ass. Prof. of Pharmaceutics, Cairo University Pharmacy Pharmacy Pharmaceutics The science of dosage form design. Pharmacy 1. 2. 3. Dosage forms Information Resources Use of
** Medication exercises ** NICU Phase II
** Medication exercises ** NICU Phase II A) Baby A has had a bowel resection six hours ago. She weighs 3 kg. Post-op, she is quite agitated and she is on a fentanyl drip at 2 micrograms/kg/hr (#1). She